Skip to main content
Torrent Pharmaceuticals Ltd. logo

Torrent Pharmaceuticals Ltd. — Investor Relations & Filings

Ticker · TORNTPHARM ISIN · INE685A01028 LEI · 335800NA6HK275RIJE13 BSE.NS Manufacturing
Open in API
Filings indexed 1,765 across all filing types
Latest filing 2023-01-12 Call Transcript
Country IN India
Listing BSE.NS TORNTPHARM

About Torrent Pharmaceuticals Ltd.

https://www.torrentpharma.com

Torrent Pharmaceuticals Ltd. is a research-driven organization focused on the development, manufacturing, and marketing of generic formulations. The company holds a significant position in therapeutic areas such as cardiovascular, central nervous system, gastrointestinal, diabetology, and anti-infective treatments. It has strategically expanded its portfolio into dermatology, nephrology, and pain management through targeted acquisitions. The firm operates across multiple international markets, supported by advanced research and development centers and manufacturing facilities that adhere to global regulatory standards. Its core operations prioritize chronic therapy leadership and the provision of high-quality healthcare solutions through a robust pipeline of generic and value-added medicines.

Recent filings

Filing Released Lang Actions
We hereby inform that the Company has scheduled a teleconference with Investors / Analyst on 25th January, 2023 at 05:30 P.M. to discuss the financial performance of the Company for the ....
Call Transcript Classification · 95% confidence The document is a letter addressed to the stock exchange listing department announcing a scheduled conference call to discuss the company's quarterly and nine months financial performance ending 31st December 2022. It provides dial-in details for the call but does not contain any financial data or results itself. The document length is short (2189 characters) and it is clearly an announcement of a conference call rather than the transcript or the financial report. Therefore, it fits the category of a Call Transcript announcement or notification. However, since it is only announcing the call and not the transcript, the best fitting category is Call Transcript (CT) as it relates to the conference call event. Confidence is high due to clear keywords like 'Post Quarterly Financial Result Conference call' and the absence of actual financial data or transcript text.
2023-01-12 English
Pursuant to Regulation 42 of Listing Regulations, the Company has fixed Friday, 3rd February, 2023 as the Record Date for taking record of the Members of the Company for the purpose of ....
Notice of Dividend Amount Classification · 95% confidence The document is a short letter addressed to the stock exchange regarding the fixing of a Record Date for the purpose of payment of an Interim Dividend, if declared by the Board. It references Regulation 42 of the SEBI Listing Regulations and specifies the date for shareholders to be recorded for dividend entitlement. The document does not contain any financial statements or detailed financial data, nor does it present a report or results. It is an announcement related to dividend payment details, specifically the Record Date for dividend entitlement. According to the filing definitions, announcements about dividend amounts, payment dates, and related shareholder details fall under the category 'Notice of Dividend Amount' (DIV). The document length is short (1760 characters), and it is clearly an announcement rather than a report. Therefore, the correct classification is DIV with high confidence.
2023-01-12 English
Record Date
Notice of Dividend Amount Classification · 95% confidence The document is a formal letter addressed to the National Stock Exchange of India regarding the intimation of a Record Date for shareholders. It specifically mentions the purpose is for deciding the shareholders entitled to an Interim Dividend if declared by the Board. The document references Regulation 42 of the SEBI Listing Regulations, which governs such disclosures. The content is an announcement about the record date and dividend-related shareholder information, not a full dividend report or financial statement. The document length is short (1820 characters), and it is clearly an announcement rather than a detailed report. Therefore, it fits the category of Notice of Dividend Amount (DIV).
2023-01-12 English
Board Meeting — Financial Results/Dividend/Other business matters
Regulatory Filings Classification · 95% confidence The document is a short notice dated 12th January 2023 from Torrent Pharmaceuticals Limited addressed to BSE Limited. It informs about the date of an upcoming Board Meeting scheduled for 25th January 2023. The purpose of the meeting includes consideration and approval of audited and unaudited financial results for the quarter and nine months ended 31-Dec-22, and consideration of interim dividend payment. The document is an intimation of a Board Meeting date and agenda, not the actual financial results or reports themselves. It is a regulatory announcement under SEBI Listing Obligations and Disclosure Requirements (LODR) Regulation 29, which mandates disclosure of Board Meeting dates. The document is short (1526 characters) and serves as a notification rather than a report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement and compliance disclosure, not as an Interim Report (IR) or Earnings Release (ER).
2023-01-12 English
TORRENT PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/01/2023 ,inter alia, to consider and approve We would like to inform ....
Regulatory Filings Classification · 95% confidence The document is a short notice informing the stock exchanges about the date of an upcoming Board Meeting where the company will consider and approve financial results and interim dividend. It is an intimation under SEBI regulations about the scheduling of a board meeting, not the financial results themselves or any detailed report. The document length is only 1526 characters, indicating it is a brief announcement rather than a full report. Therefore, it fits the category of a Regulatory Filing (RNS) as a general regulatory announcement and not a financial report or other specific filing type.
2023-01-12 English
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the stock exchange's listing department regarding the publication of newspaper advertisements about the transfer of shares to the Investor Education and Protection Fund (IEPF). It includes no financial data, no report content, and is essentially a regulatory communication about share transfer notifications. The document length is short (1263 characters), and it is an announcement for record-keeping purposes rather than a financial report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-01-10 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.